Skip to main content
KRSA
NASDAQ Life Sciences

Korsana Posts $46.4M Q3 Loss, $456.2M Cash Funds Operations Into 2029

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare
Sentiment info
Negative
Importance info
7
Price
$30.56
Mkt Cap
$1.392B
52W Low
$7.186
52W High
$59.36
52W Position info
325% above low
Off High info
49% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

KRSA has more than doubled off its 52-week low of $7.186.

Summary

Korsana closed the September merger with Cyclerion Therapeutics and a concurrent $380 million private placement, leaving it with about $456.2 million in cash as of September 30, 2026 — enough to fund operations into 2029. Third-quarter net loss was $46.4 million, or $3.19 a share, including $15.2 million of non-cash stock-based compensation, on R&D of $42.1 million and G&A of $6.1 million. The balance sheet is the story here: the company now has runway well past the first clinical readouts for its lead Alzheimer's asset KRSA-028. Phase 1 healthy volunteer data is expected mid-2027, with interim proof-of-concept data in Alzheimer's patients by year-end 2027 or the first quarter of 2028. Near-term, a preclinical poster (P338) on KRSA-028 characterization is set for presentation at CTAD on November 18, 2026. The company also added a Chief Medical Officer, a Chief Technical Officer and an audit committee chair. This follows the 8-K filed today with the same quarterly figures.

At the time of this announcement, KRSA was trading at $30.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $7.19 to $59.36. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

KRSA - Latest Insights

KRSA
Nov 05, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $30.56
Real-time Price: $32.35 info
Change: +$1.79 (+6%) info
Market Cap: $1.473B info
KRSA
Nov 05, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.56
Real-time Price: $32.35 info
Change: +$1.79 (+6%) info
Market Cap: $1.473B info
KRSA
Oct 05, 2026, 4:14 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $30.72
Real-time Price: $32.35 info
Change: +$1.63 (+5%) info
Market Cap: $1.473B info